McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...

especially in specialty products and GLP-1 medications, as well as contributions from Prescription Technology Solutions and Medical-Surgical Solutions. Furthermore, McKesson raised its fiscal 2025 ...

In the latest market close, McKesson (MCK) reached $585.24, with a +0.83% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 1.11%. Elsewhere, the ...

McKesson (MCK) closed the most recent trading day at $585.08, moving +0.57% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day. Meanwhile, ...

In the fast-evolving landscape of supply chain management, 2025 presents a unique set of challenges and opportunities for executives. As companies navigate the complexities of global business ...

After hours: January 17 at 6:47:50 PM EST ...

From research on new weight-loss drugs to the impact of artificial intelligence (AI) in medicine, 2024 has been marked by important scientific advances, especially in health. Euronews Health ...

Recently, the general public has increased its consumption of food products that have protein ... dietician with Memorial Hermann Memorial City Medical Center in Houston, who was not involved ...

KYIV, Ukraine—When the director of Russia’s largest film studio met President Vladimir Putin in the Kremlin last month, he made sure to highlight how he had supported the war effort—by ...